Which imaging technique should we use in the follow up of gynaecological cancer?

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 28, Issue 5, 2014, Pages 769-791

  Testa, Antonia Carla ^a   Di Legge, Alessia ^a   Virgilio, Bruna ^a   Bonatti, Matteo ^b   Manfredi, Riccardo ^b   Mirk, Paoletta ^a   Rufini, Vittoria ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

computed tomography; gynaecological cancer recurrences; imaging techniques; magnetic resonance imaging; positron emission tomography; ultrasound

Indexed keywords

ANTINEOPLASTIC AGENT; CONTRAST MEDIUM;

ABDOMINAL RADIOGRAPHY; ARTICLE; ASCITES; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORPHOLOGY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CARCINOMATOUS PERITONITIS; CLINICAL EXAMINATION; COLOR ULTRASOUND FLOWMETRY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION WEIGHTED IMAGING; DISEASE SEVERITY; ECHOGRAPHY; ENDOMETRIUM CANCER; ENDOMETRIUM CARCINOMA; FOLLOW UP; GYNECOLOGIC CANCER; HUMAN; IMAGE GUIDED BIOPSY; IMAGE QUALITY; LYMPH NODE METASTASIS; META ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OVARY CANCER; OVERALL SURVIVAL; PAPANICOLAOU TEST; PELVIC EXAMINATION; PHYSICAL EXAMINATION; PLEURA EFFUSION; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY AND SPECIFICITY; SEROLOGY; THREE DIMENSIONAL IMAGING; TRANSVAGINAL ECHOGRAPHY; TUMOR LOCALIZATION; TUMOR VOLUME; UTERINE CERVIX CANCER; UTERUS CANCER; UTERUS SARCOMA; DIAGNOSTIC IMAGING; ENDOMETRIAL NEOPLASMS; FEMALE; GENITAL NEOPLASMS, FEMALE; OVARIAN NEOPLASMS; PATIENT CARE; RECTUM; TUMOR RECURRENCE; UTERINE CERVICAL NEOPLASMS; UTERINE NEOPLASMS; VAGINA;

CONTINUITY OF PATIENT CARE; DIAGNOSTIC IMAGING; ENDOMETRIAL NEOPLASMS; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; NEOPLASM RECURRENCE, LOCAL; OVARIAN NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RECTUM; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; UTERINE CERVICAL NEOPLASMS; UTERINE NEOPLASMS; VAGINA;

EID: 84902299443     PISSN: 15216934     EISSN: 15321932     Source Type: Journal    
DOI: 10.1016/j.bpobgyn.2014.04.008     Document Type: Article

References (82)

1. K. Kitajima, K. Murakami, and E. Yamasaki et al. Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent uterine cancer: comparison with PET and enhanced CT Eur J Nucl Med Mol Imaging 36 2009 362 372
2. E. Sartori, B. Pasinetti, and L. Carrara et al. Pattern of failure and value of follow-up procedures in endometrial and cervical cancer patients Gynecol Oncol 107 1 Suppl 1 2007 S241 S247
3. H.B. Salvesen, L.A. Akslen, and T. Iversen et al. Recurrence of endometrial carcinoma and the value of routine follow up Br J Obstet Gynaecol 104 1997 1302 1307
4. A. Berchuck, C. Anspach, and A.C. Evans et al. Postsurgical surveillance of patients with FIGO stage I/II endometrial adenocarcinoma Gynecol Oncol 59 1995 20 24
5. Y.Y. Jeong, H.K. Kong, and T.W. Chung et al. Uterine cervical carcinoma after therapy: CT and MR imaging findings Radiographics 23 2003 968 981
6. H.K. Pannu, R.E. Bristow, and F.J. Montz et al. Multidetector CT of peritoneal carcinomatosis from ovarian cancer Radiographics 23 2003 687 701
7. S.S. Lo, U.S. Khoo, and D.K. Cheng et al. Role of serial markers in the surveillance for recurrence in endometrial cancer Cancer Detect Prev 23 1999 397 400
8. R. Forstner, H. Hricak, and C.B. Powell et al. Ovarian cancer recurrence value of MR imaging Radiology 196 1995 715 720
9. K. Reuter, T. Griffin, and R.E. Hunter Comparison of abdominopelvic computed tomography results and findings at second look laparotomy in ovarian carcinoma patients Cancer 63 1989 1123 1128
10. J. Tammela, and S. Lele New modalities in detection of recurrent ovarian cancer Curr Opin Obstet Gynecol 16 2004 5 9
11. A. Jemal, R. Siegel, and E. Ward et al. Cancer statistics CA Cancer J Clin 2007 57 2007 43 66
12. G. Ferrandina, F. Legge, and V. Salutari et al. Impact of pattern of recurrence on clinical outcome of ovarian cancer patients: clinical considerations Eur J Cancer 42 2006 2296 2302
13. R.T. Greenlee, M.B. Hill-Harmon, and T. Murray et al. Cancer statistics, 2001 CA Cancer J Clin 51 2001 15 36
14. Y. Fu, X. Wang, and Z. Pan et al. Clinical outcomes and prognostic factors of patients with epithelial ovarian cancer subjected to first-line treatment: a retrospective study of 251 cases Front Med 8 2014 91 95
15. P. Harter, and A. du Bois The role of surgery in ovarian cancer with special emphasis on cytoreductive surgery for recurrence Curr Opin Oncol 17 2005 505 514
16. C.M. Park, S.H. Kim, and S.H. Kim et al. Recurrent ovarian malignancy: patterns and spectrum of imaging findings Abdom Imaging 28 2003 404 415
17. D.M. Parkin, F. Bray, and J. Ferlay et al. Global cancer statistics, 2002 CA Cancer J Clin 55 2005 74 108
18. P. Petignat, and M. Roy Diagnosis and management of cervical cancer BMJ 335 2007 765 768
19. C.A. Perez, P.W. Grigsby, and H.M. Camel et al. Irradiation alone or combined with surgery in stage IB, IIA, and IIB carcinoma of uterine cervix: update of a nonrandomized comparison Int J Radiat Oncol Biol Phys 31 1995 703 716
20. J.H. Hong, C.S. Tsai, and C.H. Lai et al. Recurrent squamous cell carcinoma of cervix after definitive radiotherapy Int J Radiat Oncol Biol Phys 60 2004 249 257
21. P. Morice, C. Deyrolle, and A. Rey et al. Value of routine follow-up procedures for patients with stage I/II cervical cancer treated with combined surgery-radiation therapy Ann Oncol 15 2004 218 223
22. E. Sartori, B. Pasinetti, and F. Chiudinelli et al. Surveillance procedures for patients treated for endometrial cancer: a review of the literature Int J Gynecol Cancer 20 2010 985 992
23. S. Pignata, G. Scambia, C. Pisano Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies Group A multicentre phase II study of carboplatin plus pegylated liposomal doxorubicin as first-line chemotherapy for patients with advanced or recurrent endometrial carcinoma: the END-1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) group Br J Cancer 96 2007 1639 1643
24. M. Fung-Kee-Fung, J. Dodge, L. Elit Cancer Care Ontario Program in Evidence-based Care Gynecology Cancer Disease Site Group Follow-up after primary therapy for endometrial cancer: a systematic review Gynecol Oncol 101 2006 520 529
25. S.B. Korets, and J.P. Curtin Surgical options for recurrent uterine sarcomas Am Soc Clin Oncol Educ Book 32 2012 362 366
26. A. Gadducci Prognostic factors in uterine sarcoma Best Pract Res Clin Obstet Gynaecol 25 2011 783 795
27. C.A. Meanwell, E.B. Rolfe, and G. Blackledge et al. Recurrent female pelvic cancer: assessment with transrectal ultrasonography Radiology 162 1 Pt 1 1987 278 281
28. E. Volpi, P. Zola, and T. De Grandis et al. Transvaginal sonography in the diagnosis of pelvic malignant recurrence: integration of sonography and needle-guided biopsy Ultrasound Obstet Gynecol 4 1994 135 138
29. A.C. Testa, E. Fruscella, and M. Ludovisi et al. The role of sonographic examination in the follow-up of gynecological neoplasms Gynecol Oncol 99 2005 696 703
30. L. Savelli, A.C. Testa, and G. Ferrandina et al. Pelvic relapses of uterine neoplasms: transvaginal sonographic and Doppler features Gynecol Oncol 93 2004 441 445
31. A.C. Testa, M. Ciampelli, and C. Mastromarino et al. Detection of central pelvic recurrent disease with transvaginal color Doppler ultrasound in women treated for gynecological malignancy Ultrasound Obstet Gynecol 19 2002 490 495
32. D. Fischerova Ultrasound scanning of the pelvis and abdomen for staging of gynecological tumors: a review Ultrasound Obstet Gynecol 38 2011 246 266
33. A.C. Testa, C. Van Holsbeke, and F. Mascilini et al. Dynamic and interactive gynecological ultrasound examination Ultrasound Obstet Gynecol 34 2009 225 229
34. H.K. Pannu, K.M. Horton, and E.K. Fishman Thin section dual-phase multidetector-row computed tomography detection of peritoneal metastases in gynecologic cancers J Comput Assist Tomogr 27 2003 333 340
35. P. Gu, L.L. Pan, and S.Q. Wu et al. CA 125, PET alone, PET-CT, CT and MRI in diagnosing recurrent ovarian carcinoma: a systematic review and meta-analysis Eur J Radiol 71 2009 164 174
36. E. Sala, M. Kataoka, and N. Pandit-Taskar et al. Recurrent ovarian cancer: use of contrast-enhanced CT and PET/CT to accurately localize tumor recurrence and to predict patients' survival Radiology 257 2010 125 134
37. S.A. Funt, H. Hricak, and N. Abu-Rustum et al. Role of CT in the management of recurrent ovarian cancer Am J Roentgenol 182 2004 393 398
38. R.N. Low, R.M. Barone, and C. Lacey et al. Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium-containing contrast agents compared with unenhanced MR imaging and CT Radiology 204 1997 513 520
39. S. Patel, S.H. Liyanage, and A. Sahdev et al. Imaging of endometrial and cervical cancer Insights Imaging 1 2010 309 328
40. M. Franchi, A. La Fianza, and L. Babilonti et al. Clinical value of computerized tomography (CT) in assessment of recurrent uterine cancers Gynecol Oncol 35 1 1989 Oct 31 37
41. J.W. Kwek, and R.B. Iyer Recurrent ovarian cancer: spectrum of imaging findings Am J Roentgenol 187 2006 99 104
42. L. Prayer, C. Kainz, and J. Kramer et al. CT and MR accuracy in the detection of tumor recurrence in patients treated for ovarian cancer J Comput Assist Tomogr 17 1993 626 632
43. E.K. Outwater, E.S. Siegelman, and K.M. Wilson et al. Benign and malignant gynecologic disease: clinical importance of fluid and peritoneal enhancement in the pelvis at MR imaging Radiology 200 1996 483 488
44. C.K. Kim, B.K. Park, and J.Y. Choi et al. Detection of recurrent ovarian cancer at MRI: comparison with integrated PET/CT J Comput Assist Tomogr 31 2007 868 875
45. S.H. Kim, and M.C. Han Invasion of the urinary bladder by uterine cervical carcinoma: evaluation with MR imaging AJR Am J Roentgenol 168 1997 393 397
46. R. Manfredi, S. Baltieri, and A. Tognolini et al. Recurrent uterine cancer after surgery: magnetic resonance imaging patterns and their changes after concomitant chemoradiation Radiol Med 113 2008 1143 1156
47. K. Kinkel, M. Ariche, and A.A. Tardivon et al. Differentiation between recurrent tumor and benign conditions after treatment of gynecologic pelvic carcinoma: value of dynamic contrast-enhanced subtraction MR imaging Radiology 204 1997 55 63
48. A. Nishie, A.H. Stolpen, and M. Obuchi et al. Evaluation of locally recurrent pelvic malignancy: performance of T2- and diffusion-weighted MRI with image fusion J Magn Reson Imaging 28 2008 705 713
49. W.T. Yang, W.W. Lam, and M.Y. Yu et al. Comparison of dynamic helical CT and dynamic MR imaging in the evaluation of pelvic lymph nodes in cervical carcinoma AJR Am J Roentgenol 175 2000 759 766
50. A.M. De Gaetano, M.L. Calcagni, and V. Rufini et al. Imaging of gynecologic malignancies with FDG PET-CT: case examples, physiologic activity, and pitfalls Abdom Imaging 34 2009 696 711
51. L. Gorospe, R. Jover-Díaz, and A. Vicente-Bártulos Spectrum of PET-CT pelvic pitfalls in patients with gynecologic malignancies Abdom Imaging 37 2012 1041 1065
52. C.H. Lai, K. Huang, and L.C. See et al. Restaging of recurrent cervical carcinoma with dual-phase [18F]Fluoro-2-Deoxy-D-Glucose positron emission tomography Cancer 100 2004 544 552
53. K. Kitajima, Y. Ueno, and K. Suzuki et al. Low-dose non-enhanced CT versus full-dose contrast-enhanced CT in integrated PET/CT scans for diagnosing ovarian cancer recurrence Eur J Radiol 81 2012 3557 3562
54. K. Kitajima, K. Suzuki, and Y. Nakamoto et al. Low-dose non-enhanced CT versus full-dose contrast-enhanced CT in integrated PET/CT studies for the diagnosis of uterine cancer recurrence Eur J Nucl Med Mol Imaging 37 2010 1490 1498
55. H.A. Vargas, I.A. Burger, and O.F. Donati et al. Magnetic resonance imaging/positron emission tomography provides a roadmap for surgical planning and serves as a predictive biomarker in patients with recurrent gynecological cancers undergoing pelvic exenteration Int J Gynecol Cancer 23 2013 1512 1519
56. K. Kitajima, Y. Suenaga, and Y. Ueno et al. Value of fusion of PET and MRI in the detection of intra-pelvic recurrence of gynecological tumor: comparison with 18F-FDG contrast-enhanced PET/CT and pelvic MRI Ann Nucl Med 28 2014 25 32
57. E. Sala, M. Kataoka, and N. Pandit-Taskar et al. Recurrent ovarian cancer: use of contrast-enhanced CT and PET/CT to accurately localize tumor recurrence and to predict patients' survival Radiology 257 2010 125 134
58. S. Dragosavac, S. Derchain, and N.M. Caserta et al. Staging recurrent ovarian cancer with (18)FDG PET/CT Oncol Lett 5 2013 593 597
59. H.H. Chung, W.J. Kang, and J.W. Kim et al. Role of [18F]FDG PET/CT in the assessment of suspected recurrent ovarian cancer: correlation with clinical or histological findings Eur J Nucl Med Mol Imaging 34 2007 480 486
60. L. Antunovic, M. Cimitan, and E. Borsatti et al. Revisiting the clinical value of 18F-FDG PET/CT in detection of recurrent epithelial ovarian carcinomas: correlation with histology, serum CA-125 assay, and conventional radiological modalities Clin Nucl Med 37 2012 e184 e188
61. S. Risum, C. Høgdall, and E. Markova et al. Influence of 2-(18F) fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography on recurrent ovarian cancer diagnosis and on selection of patients for secondary cytoreductive surgery Int J Gynecol Cancer 19 2009 600 604
62. A. Fagotti, F. Fanfani, and C. Rossitto et al. Oncology 75 2008 152 158
63. Y.M. Chen, T. Chen, and C.S. Zee et al. Is there an impact of 18F-FDG PET/CT on the surveillance and clinical management of recurrent ovarian cancer? Research based on a large sample in a single PET/CT center Nucl Med Commun 35 2014 347 352
64. Z. Limei, C. Yong, and X. Yan et al. Accuracy of positron emission tomography/computed tomography in the diagnosis and restaging for recurrent ovarian cancer: a meta-analysis Int J Gynecol Cancer 23 2013 598 607
65. B. Simcock, D. Neesham, and M. Quinn et al. The impact of PET/CT in the management of recurrent ovarian cancer Gynecol Oncol 103 2006 271 276
66. M.J. Fulham, J. Carter, and A. Baldey et al. The impact of PET-CT in suspected recurrent ovarian cancer: a prospective multi-centre study as part of the Australian PET Data Collection Project Gynecol Oncol 112 2009 462 468
67. K. Kitajima, K. Murakami, and E. Yamasaki et al. Performance of FDG-PET/CT for diagnosis of recurrent uterine cervical cancer Eur Radiol 18 2008 2040 2047
68. Y. Ebina, H. Watari, and M. Kaneuchi et al. Impact of FDG PET in optimizing patient selection for cytoreductive surgery in recurrent ovarian cancer Eur J Nucl Med Mol Imaging 41 2014 446 451
69. M. Murakami, T. Miyamoto, and T. Iida et al. Whole-body positron emission tomography and tumor marker CA125 for detection of recurrence in epithelial ovarian cancer Int J Gynecol Cancer 16 suppl 1 2006 99 107
70. L.J. Havrilesky, S.L. Kulasingam, and D.B. Matchar et al. FDG-PET for management of cervical and ovarian cancer Gynecol Oncol 97 2005 183 191
71. A. Palomar, C. Nanni, and P. Castellucci et al. Value of FDG PET/CT in patients with treated ovarian cancer and raised CA125 serum levels Mol Imaging Biol 14 2012 123 129
72. N. Khan, N. Oriuchi, and A. Yoshizaki et al. Diagnostic accuracy of FDG PET imaging for the detection of recurrent or metastatic gynecologic cancer Ann Nucl Med 19 2005 137 145
73. P. Bhosale, S. Peungjesada, and W. Wei et al. Clinical utility of positron emission tomography/computed tomography in the evaluation of suspected recurrent ovarian cancer in the setting of normal CA-125 levels Int J Gynecol Cancer 20 2010 936 944
74. T.C. Chang, K.S. Law, and J.H. Hong et al. Positron emission tomography for unexplained elevation of serum squamous cell carcinoma antigen levels during follow-up for patients with cervical malignancies: a phase II study Cancer 101 2004 164 171
75. J.B. Unger, J.J. Ivy, and P. Connor et al. Detection of recurrent cervical cancer by whole-body FDG PET scan in asymptomatic and symptomatic women Gynecol Oncol 94 2004 212 216
76. S.Y. Ryu, M.H. Kim, and S.C. Choi et al. Detection of early recurrence with 18F-FDG PET in patients with cervical cancer J Nucl Med 44 2003 347 352
77. A. Chao, T.C. Chang, and K.K. Ng et al. 18F-FDG PET in the management of endometrial cancer Eur J Nucl Med Mol Imaging 33 2006 36 44
78. J.Y. Park, E.N. Kim, and D.Y. Kim et al. Role of PET or PET/CT in the post-therapy surveillance of uterine sarcoma Gynecol Oncol 109 2008 255 262
79. Y.H. Kao, U. Saad, and A.E. Tan et al. Fluorine-18-fluorodeoxyglucose PET/CT for the evaluation of suspected recurrent uterine leiomyosarcomas Acta Radiol 52 2011 463 466
80. P. Sharma, R. Kumar, and H. Singh et al. Carcinoma endometrium: role of 18-FDG PET/CT for detection of suspected recurrence Clin Nucl Med 37 2012 649 655
81. H.W. Kim, K.S. Won, and S.K. Zeon et al. Peritoneal carcinomatosis in patients with ovarian cancer: enhanced CT versus 18F-FDG PET/CT Clin Nucl Med 38 2013 93 97
82. S.Y. Ma, L.C. See, and C.H. Lai et al. Delayed (18)F-FDG PET for detection of paraaortic lymph node metastases in cervical cancer patients J Nucl Med 44 2003 1775 1783